Dermatology Times, Evidence-Based Cleansing and Moisturizing Practices for Protecting and Repairing the Skin Barrier, November 2025 (Vol. 46. Supp. 09) ...

Awareness Spotlight | Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights.

Join host Cynthia Trickett, MPAS, PA-C, for a video podcast on hidradenitis suppurativa (HS), joined by Leigh Ann Pansch, MSN, FNP-BC, DCNP; Buchi Neita, PA-C, MCMSc; and Victor Czerkasij, DCNP, FNP-C ...

ET-02 showed significant hair growth, surpassing minoxidil's results in a shorter timeframe, with no safety concerns observed. The drug targets stem cell biology, correcting defects causing hair loss, ...

Across social media, castor oil is frequently promoted as a natural solution for thinning hair, sparse eyebrows, and slow hair growth. Users massage the thick oil directly into th ...

Gelfand described psoriasis as an inflammatory metabolic disease. Among inflammatory diseases of medicine, he said psoriasis has by far the closest association with obesity. Obesity makes psoriasis ...

A methodical up-titration schedule and clear expectations help patients reach the point where advanced therapy is appropriate. With no approved CIndU medication, clinicians are extrapolating from CSU.

Krakowski, MD, welcomes Lawrence Eichenfield, MD, pediatric dermatologist, to discuss topical corticosteroid potency, dosing, and where they fit alongside nonsteroidal agents. Lawrence Eichenfield, MD ...

The US Food and Drug Administration (FDA) has approved pritelivir (HOVILPRI; Asahi Kasei Therapeutics) 100-mg tablets for the ...

Christopher Bunick, MD, PhD, reviews data on investigational atopic dermatitis agents presented at EADV 2026 and biomarker ...

Remibrutinib is approved for chronic spontaneous urticaria (CSU) and most recently, symptomatic dermographism, with the label ...